LNC Therapeutics

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
LNC Therapeutics is a French biotech company specializing in the research and development of therapeutic innovations harnessing the potential of the gut microbiome.

The company is developing a new class of drugs—single strain live biotherapeutic products (LBPs). Its most advanced development program aims to begin in-human clinical trials of an initial product targeting obesity and metabolic diseases. Its portfolio includes other innovative programs in the treatment of indications with substantial unmet medical needs and protected by a vast patent portfolio.

Supported by leading venture capital investors, such as Seventure Partners, and family offices, LNC Therapeutics has established collaborative projects worldwide with renowned scientific experts to maintain the highest standards in its development of innovative biotherapeutics.
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
France
Year Founded:
2010
Main Therapeutic Focus:
Lead Product in Development:
LNC01 program
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
LNC Therapeutics